3/31/2015
Investor Presentation of the Week
Newtek Investor Luncheon with Chief Executive Office, Barry Sloane December 30, 2014

Newtek investor luncheon_12_30_14_final
Free signup
  • FREE RESEARCH REPORTS ($250 value)
  • WEEKLY BRIEFINGS ON EMERGING GROWTH COMPANIES

BioRestorative Therapies, Inc. (BRTX): The Next Big Thing in Stem Cell Biotechnology - Part 1

BioRestorative Therapies, Inc. (BRTX): The Next Big Thing in Stem Cell Biotechnology

Tobin Smith of NBT Equities Research interviews Mark Weinreb, CEO of BioRestorative Therapies, Inc. (BRTX)

©2010-2014 NBT Group. All Rights Reserved  |  Privacy Policy
Website Design by Amanda Besemer + Co.